Granules India To Buy Auctus Pharma For $19.4 Million
This article was originally published in PharmAsia News
Executive Summary
Granules India said it would acquire fellow India drug maker Auctus Pharma for $19.4 million, gaining two production facilities approved by leading regulators and the World Health Organization.